Pharmaceutical companies operate in high-stakes environments where cybersecurity breaches can have devastating consequences. With an average breach cost of USD 5.1 million, the stakes are high, especially given the sensitivity of the data involved, including R&D findings, clinical trial IP, and patient records. As the industry becomes more digitised, the imperative to implement robust cybersecurity strategies grows exponentially.

Legacy Systems: A Weak Link in the Security Chain

Reliance on outdated technologies significantly increases vulnerability in the pharmaceutical sector. This risk is further intensified by the integration of legacy Operational Technology (OT) systems with modern cloud-based IT infrastructures, creating complex hybrid environments. OT systems often lack native security features, and once connected to the cloud, they become potential conduits for attackers to infiltrate critical data stores, disrupt operations, or steal intellectual property.

To safeguard both data and operations, pharma companies must implement a unified security framework that includes strict access controls, continuous monitoring, and real-time threat detection. These are core pillars of a robust Exposure Management strategy.

AI-Driven Threats and the Looming Risk of Inaction

According to the India Cyber Threat Report 2025, the cyber threat landscape this year will be dominated by AI-driven attacks, with cybercriminals using generative AI to develop more adaptive and sophisticated threats, including AI-powered malware. Unfortunately, many legacy OT systems are ill-equipped to defend against these rapidly evolving threats.

Their lack of regular updates and inherent design flaws make them especially vulnerable to ransomware, malware, and zero-day exploits. In this environment, traditional security approaches are no longer sufficient. Exposure Management offers a modern, proactive alternative, enabling continuous visibility to detect, prioritise, and mitigate these critical vulnerabilities.

Integrated Security for Hybrid Ecosystems

As pharmaceutical companies increasingly adopt AI and digital technologies, they are building hybrid ecosystems that blend cloud, on-premises, and OT infrastructure. While these innovations drive productivity and insights, they also introduce significant cybersecurity complexity and expand the attack surface.

Exposure Management platforms are purpose-built to secure this landscape, offering protection across IT, cloud, and critical infrastructure. These platforms reduce risk by identifying and remediating misconfigurations, risky entitlements, and vulnerabilities before attackers can exploit them.

They also integrate seamlessly with widely used third-party tools for EDR, cloud security, vulnerability management, OT protection, and ticketing systems, enabling holistic security monitoring. Through unified dashboards and customizable reporting, they eliminate the inefficiencies of manual processes and help security teams deliver actionable insights that drive faster, better-informed decisions.

Also read: Transforming Patient Care with Needle-Free Injections and Smart Design

From Fragmented Defences to Unified Protection

The convergence of ageing OT systems with modern cloud infrastructure significantly amplifies pharma’s cybersecurity exposure. A breach in such a hybrid environment can cascade across systems, compromise clinical research, disrupt production, and even jeopardise patient safety.

To counter these escalating threats, pharmaceutical companies must transition from siloed defences to an integrated cybersecurity strategy. Exposure Management platforms empower organisations to:

• Achieve continuous, real-time visibility across their IT-OT landscape
• Detect and respond to threats proactively
• Prevent lateral movement across environments
• Close critical security gaps efficiently

In an era defined by the rise of sophisticated AI-powered cyberattacks, Exposure Management is no longer optional — it is essential. By embracing unified protection, pharmaceutical companies can secure their digital future while maintaining trust, safety, and operational resilience.

Views expressed by: Rajnish Gupta, Managing Director & Country Manager, Tenable India

Like 1

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!